Every Form 4 that Aclarion, Inc. (ACON) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ACON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACON filings page.
Aclarion, Inc. (ACON) director Amanda M. Williams reported a purchase of Aclarion common stock. On August 17, 2026, she bought 5,857 shares of common stock in a public market transaction at $2.73 per share. Following this open-market purchase, she directly owns 25,857 shares of Aclarion common stock. The filing indicates the trade was not made under a Rule 10b5-1 trading plan.
Aclarion, Inc. CFO Gregory A. Gould reported an open-market purchase of 10,000 shares of ACON common stock on August 14, 2026 at $2.45 per share, as disclosed in a footnote stating the shares were bought on the public market. Following this transaction, he directly holds 60,000 common shares. The transaction is classified as a purchase in an open market or private transaction and is not reported as executed under a Rule 10b5-1 trading plan.
Aclarion, Inc. director Ryan Bond reported an open-market purchase of Aclarion common stock. On August 13, 2026, he purchased 21,122 shares of common stock at $2.37 per share on the public market. Following this transaction, his direct holdings increased to 76,122 shares of Aclarion common stock. The filing indicates the Rule 10b5-1 trading-plan checkbox was not selected.
Aclarion, Inc. director Wesemann William purchased additional ACON common stock. On August 13, 2026, he bought 2,150 shares of common stock in a public market transaction at $2.34 per share, increasing his direct holdings to 23,713 shares. The filing indicates this transaction was not made pursuant to a Rule 10b5-1 trading plan.
Aclarion, Inc. director Neal David K reported an open-market purchase of 7,500 shares of Aclarion common stock on August 13, 2026 at $2.40 per share. Following this transaction, he directly holds 30,002 shares of Aclarion common stock.
Aclarion, Inc. Chief Executive Officer Brent Ness purchased 5,234 shares of ACON common stock on 08/13/2026 in a public market transaction at $2.31 per share. Following this open-market purchase, he directly owns 111,534 shares of Aclarion common stock.
Bond Ryan reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. reported that Chief Strategy Officer Ryan Bond received an equity grant of 55,000 restricted stock units on 6/11/2026 under the company’s equity incentive plan. Each RSU equals one share of common stock and 100% of the award is scheduled to vest on 6/1/2027, with full acceleration upon a qualifying change of control.
Sequira Amanda Mae reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. director Amanda Mae Sequira received an award of 20,000 restricted stock units (RSUs) of common stock on 6/11/2026 under the company’s equity incentive plan. Each RSU represents the right to receive one Aclarion share if vesting conditions are met.
The filing states that 100% of these RSUs will vest on 6/1/2027. Any RSUs still unvested at that time will also fully vest if a change of control, as defined in the equity incentive plan, occurs before then. After this grant, Sequira directly holds 20,000 shares/RSUs.
Breidbart Scott reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. director Scott Breidbart received an equity grant in the form of restricted stock units. He was awarded 20,000 RSUs on 6/11/2026 under the company’s equity incentive plan, with each unit representing one share of ACON common stock.
All of these RSUs are scheduled to vest on 6/1/2027, meaning he will receive the underlying shares at that time if conditions are met. Any unvested RSUs will fully vest earlier if there is a change of control as defined in the plan. Following this award, Breidbart directly holds 25,664 shares.
Gould Gregory A reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. reported that Chief Financial Officer Gregory A. Gould received an equity compensation grant in the form of restricted stock units. On 6/11/2026 he was awarded 50,000 RSUs, each representing a contingent right to receive one share of Aclarion common stock.
All 50,000 RSUs are scheduled to vest on 6/1/2027, meaning the shares will be delivered if he remains eligible through that date. Any outstanding and unvested RSUs will also fully vest if a change of control occurs as defined in the company’s equity incentive plan. Following this grant, Gould holds 50,000 shares directly reported in this filing.
Ness Brent reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. reported that Chief Executive Officer Brent Ness received an equity award in the form of 100,000 restricted stock units (RSUs) on June 11, 2026 under the company’s equity incentive plan. Each RSU represents a right to receive one share of ACON common stock.
The Form 4 shows the RSUs at a grant price of $0.00 per unit, reflecting a compensation award rather than a market purchase. All of the RSUs are scheduled to vest on June 1, 2027, and any unvested RSUs will fully vest if a change of control occurs as defined in the plan. Following this grant, Ness is shown holding 106,300 common shares directly.
Wesemann William reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. director William Wesemann received an equity award of 20,000 restricted stock units. The RSUs were granted on 6/11/2026 under the company’s equity incentive plan and each unit represents one share of ACON common stock. All RSUs are scheduled to vest on 6/1/2027, with any unvested units fully vesting if a change of control occurs. Following this grant, Wesemann directly holds 21,563 shares of common stock.
Thramann Jeffrey John reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. reported that Executive Chairman Jeffrey John Thramann received a grant of 100,000 restricted stock units (RSUs) of common stock. Each RSU represents a contingent right to receive one share of Aclarion common stock.
All of the RSUs are scheduled to vest on June 1, 2027, and any outstanding unvested RSUs will fully vest if a change of control occurs as defined under the company’s equity incentive plan. Following this grant, Thramann holds 100,000 shares/RSUs directly.
Neal David K reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. director Neal David K reported an equity compensation grant. He received 20,000 restricted stock units (RSUs) on 6/11/2026 under the company’s equity incentive plan, each representing one future share of common stock. Following this award, he now holds 22,502 shares of common stock directly.
The filing notes that 100% of the RSUs vest on 6/1/2027, meaning he must remain eligible through that date to receive the underlying shares. Any unvested RSUs will also fully vest if there is a change of control as defined in the company’s equity incentive plan.
Deitsch Stephen reported acquisition or exercise transactions in this Form 4 filing.
Aclarion, Inc. director Stephen Deitsch received an equity grant of 20,000 restricted stock units (RSUs). The award was granted on 6/11/2026 under Aclarion's equity incentive plan at no cash cost per unit, with each RSU representing the right to receive one share of common stock.
According to the terms, 100% of the RSUs will vest on 6/1/2027, and any unvested RSUs will fully vest if there is a change of control as defined in the company’s equity incentive plan. Following this grant, Deitsch holds 20,000 shares/units directly.
Aclarion, Inc. director Scott Breidbart made an open-market purchase of Common Stock. On May 12, 2026, he bought 5,664 shares at a price of $3.18 per share in a public market transaction. Following this trade, his directly held position stands at 5,664 shares.
Aclarion, Inc. director Neal David K completed an open-market purchase of 2,500 shares of Aclarion common stock on May 11, 2026. The shares were bought at an average price of $3.10 per share. Following this transaction, he directly holds 2,502 common shares of Aclarion.
Aclarion, Inc. director and CEO Brent Ness reported an open-market purchase of company stock. He bought 6,289 shares of Common Stock on the public market at a price of $3.18 per share. After this transaction, he directly owns 6,300 shares of Aclarion Common Stock.
Aclarion, Inc. director William Wesemann bought shares of the company in the open market. On 5/6/2026, he completed an open-market purchase of 1,562 shares of Aclarion common stock at a price of $3.30 per share. After this transaction, his direct holdings total 1,563 common shares.